FDA Inspection 1022105 — Navinta, LLC

Navinta, LLC — FEI 3004375014

The FDA completed an inspection of Navinta, LLC on Aug 18, 2017 in Ewing, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 18, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Postmarket Surv. and Epidemiology
Location
Ewing, NJ (United States)

Citations

IDCFRDescription
1802521 CFR 314.80(c)(2)(ii)(B)Late submission of an ICSR
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report
683321 CFR 314.80(c)(2)(ii)(A)Incomplete periodic safety report
684221 CFR 314.80(j)Failure to maintain records

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.